Frequency of Sexual Dysfunction In Women With Rheumatic Diseases PDF Print E-mail
Sunday, 07 July 2013 20:08
Sexuality is part of human life and of quality of life, accounting for individual well-being. It relates not only to sexual intercourse itself, but also to a whole spectrum that ranges from self-image and self-valuing to relationship with the ‘Other’. Appropriate sexual activity comprises phases from sexual arousal to relaxation, with pleasure and satisfaction.

Sexual dysfunction is a change in a phase of the sexual activity that can culminate in frustration, pain, and a reduction in the number of sexual intercourses. Some studies have shown a prevalence of sexual dysfunction in the general female population of as much as 40%. Chronic diseases are known to influence the quality of sexual life, but their effect is little studied, and sexual dysfunction, little diagnosed. This is due to two reasons: patients do not report their sexual dysfunctions because of shame or frustration, and physicians rarely ask their patients about those dysfunctions.

When asked, health professionals allege to have little time for consultation, lack of privacy in their medical offices, and lack of ability to discuss the issue. In addition, patients tend to avoid speaking about that subject. Recently, the Association Nationale de Défense Contre l’Arthrite Rhumatoïde (French Association for Rheumatoid Arthritis) has sent, via e-mail, a questionnaire about sexuality to their members. Only 38% responded, and 70% reported a negative impact of the disease on their sexual life. Seventy-two per cent reported never having spoken with their physicians about sexuality.

Studies on the Brazilian population that could help to delineate the real impact of rheumatic diseases on sexual functioning still lack. Knowing the extension of the problem is necessary, so that therapeutic possibilities can be provided, because sexual dysfunction is one of the major determinants of reduced quality of life.

This study aimed at assessing the prevalence of sexual dysfunction in women followed up in the Rheumatology Outpatient Clinic of the Hospital Universitário de Brasília (HUB) and the Hospital das Clínicas of the Universidade de São Paulo (HC-FMUSP), who have the following rheumatic diseases: systemic lupus erythematosus (SLE); rheumatoid arthritis (RA); systemic sclerosis (SSc); antiphospholipid antibody syndrome (APLS); and fibromyalgia (FM).

To continue reading the full study, please download from the link provided below.

 
More articles :

» Scleroderma and Lupus Health Study Claims No Environmental Link To Disease

The Massachusetts Department of Public Health (DPH) has released the results of an investigation into the occurrence of and lupus, two rare chronic diseases, in South Boston. The investigation found that the prevalence of scleroderma was indeed...

» U.S. Legislation Passed to Promote Research and Awareness of Scleroderma

(U.S.) has applauded the U.S. House of Representatives for the passage of the Scleroderma Research and Awareness Act (H.R. 2408), introduced last March by Rep. Lois Capps (D-CA) and Rep. Vern Ehlers (R-MI). This bipartisan legislation gives hope to...

» Important Information On Flaxseed And Flaxseed Oil

Flaxseed, called linseed in some countries, is a good source of dietary fiber, , and . Each of these components may contribute to the health effects of eating flaxseed, but flaxseed oil contains no fiber and very little lignan. In addition to its...

» Systemic Sclerosis: An Update

Systemic sclerosis (SSc) is a clinically heterogeneous, systemic disorder affecting connective tissue of skin, internal organs, and walls of blood vessels. It is characterized by alterations of the microvasculature in the form of hypoxia, digital...

» Long-Term Outcomes of Scleroderma Renal Crisis

In a previous study. researchers sought to describe the medical history of a group of patients with Scleroderma Renal Crisis who had been treated with ACE inhibitors. The following is essentially a summary of that study, which was conducted by...

» An Approach to the Treatment of Scleroderma

Systemic sclerosis is unique among the rheumatic diseases because it presents the challenge of managing a chronic multisystem autoimmune disease with a widespread obliterative vasculopathy of small arteries that is associated with varying degrees of...

Comments  

 
+1 #1 cindy haan 2013-07-09 14:10
Taking any antidepressants along with scleroderma and having Pulmonary hypertension that often occurs with it...makes the dysfunction much worse. Noticed it as soon as I took Zoloft and cymbalta.
Report to administrator